The influence of protein binding on the antibacterial activity of faropenem against Haemophilus influenzae  I. Gustafsson, O. Cars  Clinical Microbiology.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens.
Activity of imipenem against VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae in the murine thigh infection model  G.L. Daikos, A. Panagiotakopoulou,
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
R. Colodner, O. Nitzan, B. Chazan, H. Edelstein, R. Raz 
Migrant health—a cause for concern?
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
E. Lindberg, I. Adlerberth, A.E. Wold 
R. Cantón  Clinical Microbiology and Infection 
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
An eye-catching acanthocephalan
Surveillance of Legionnaires’ disease in Austria
Results from a mathematical model for human monocytic ehrlichiosis
D.G. Scorpio, J. Garyu, N. Barat, J. Stephen Dumler 
S. Khelaifia, M. Drancourt  Clinical Microbiology and Infection 
Vector control: a cornerstone in the malaria elimination campaign
Training for the infectious diseases speciality in Norway
Rotavirus vaccination: a concise review
CMI editorial report 2011 Clinical Microbiology and Infection
The clinical efficacy of triclosan/copolymer and other common therapeutic approaches to periodontal health  R.M. Davies  Clinical Microbiology and Infection 
Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against Gram-positive and Gram-negative bacteria  Inga Odenholt, Elisabeth Löwdin,
Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes  S. Ladhani,
M. Or, M. Samish, T. Waner, S. Harrus 
Levofloxacin in the treatment of ventilator-associated pneumonia
Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study  M.R. Berndsen,
Metagenomics and probiotics
Selection of rifampicin-resistant Mycobacterium tuberculosis does not occur in the presence of low concentrations of rifaximin  Ornella Soro, Adelaide.
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
Laboratory diagnosis of Clostridium difficile disease
W.A. Craig  Clinical Microbiology and Infection 
A. Bryskier  Clinical Microbiology and Infection 
The practice of travel medicine in Europe
Long-term mortality following bloodstream infection
Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens.
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
A novel fluorescence in situ hybridization test for rapid pathogen identification in positive blood cultures  A. Makristathis, S. Riss, A.M. Hirschl 
Vaccinations against respiratory tract infections at Hajj
Reducing antibiotic use in influenza: challenges and rewards
A.P. Underwood, J. Green  Clinical Microbiology and Infection 
Fibronectin concentrations in catheter sepsis
Antimicrobial drug development – the past, the present, and the future
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
An after-hours clinical liaison blood culture service—is it worth it?
Influenza A(H1N1)2009 in the French Pacific territories: assessment of the epidemic wave during the austral winter  Epidemiological Task Group for Overseas.
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Can pharmacokinetic–pharmacodynamic parameters provide dosing regimens that are less vulnerable to resistance?  P. Courvalin  Clinical Microbiology and.
The in vitro activity of moxifloxacin against Haemophilus influenzae and Moraxella catarrhalis explored using a pharmacodynamic model  Alasdair P. MacGowan,
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Abstracts Clinical Microbiology and Infection
Virology: a scientific discipline facing new challenges
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Are we losing the fight against malaria one more time?
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
The first glycopeptide-intermediate Staphylococcus aureus in Oman
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

The influence of protein binding on the antibacterial activity of faropenem against Haemophilus influenzae  I. Gustafsson, O. Cars  Clinical Microbiology and Infection  Volume 10, Issue 10, Pages 934-937 (October 2004) DOI: 10.1111/j.1469-0691.2004.00977.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 1 The effects of different concentrations of faropenem against Haemophilus influenzae strain LH 2803. The solid lines represent media containing human albumin 20 g/L and the dotted lines represent broth cultures. Results shown are the means of three experiments. Clinical Microbiology and Infection 2004 10, 934-937DOI: (10.1111/j.1469-0691.2004.00977.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions

Fig. 2 Killing effects of faropenem 12 mg/L against Haemophilus influenzae strains 2045 and 405298. The solid lines represent the culture medium with inactivated human serum 50% v/v and the dotted lines represent broth. Growth controls from the medium with serum are included. Bars indicate the standard deviation observed with three experiments. Clinical Microbiology and Infection 2004 10, 934-937DOI: (10.1111/j.1469-0691.2004.00977.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions